Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer

CURRENT MEDICINAL CHEMISTRY · Published 2026-07-08 · DOI 10.2174/0109298673456272260331094939

Authors (4)

Ruyue Chen, Zengwu Yao, Lixin Jiang, Jinchen Hu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Chen, R., Yao, Z., Jiang, L., et al. (2026). Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer. CURRENT MEDICINAL CHEMISTRY. https://doi.org/10.2174/0109298673456272260331094939

Related articles